학술논문
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
Document Type
Article
Author
Hezel, A.F.; Noel, M.S.; Connolly, G.C.; Allen, J.N.; Faris, J.E.; Goyal, L.; Clark, J.W.; Blaszkowsky, L.S.; Murphy, J.E.; Sheehan, S.; Harris, D.J.; Ryan, D.P.; Zhu, A.X.; Abrams, T.A.; Yurgelun, M.; Ng, K.; Regan, E.; Fuchs, C.; Zheng, H.; Khorana, A.A.; Hyrien, O.; Baran, A.; Herr, M.; Borger, D.R.; Iafrate, A.J.
Source
In: British Journal of Cancer . (British Journal of Cancer, 29 July 2014, 111(3):430-436)
Subject
Language
English
ISSN
15321827
00070920
00070920